Clinical trial
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary…
NCT00094484 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00094484 |
|---|---|
| Title | Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis |
| Official title | A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Disease, Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Cinacalcet HCl |
| Enrollment | 400 |
| Start date | Oct 1, 2004 |
| First posted | Oct 20, 2004 |
| Last update posted | May 8, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: